Federal award
SIEMENS HEALTHCARE SL.
N6817121P6130
Contract
Obligated and Ceiling
- Obligated (net)
- $185,457.94
- Ceiling (potential value, not spending)
- $185,457.94
- Current value
- $185,457.94
- Gross positive obligations
- $186,402.29
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- SIEMENS HEALTHCARE SL. · J5YJEL7TYQ81
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- SIEMENS AKTIENGESELLSCHAFT · RDB2AM2GGHH8
- Awarding agency
- Department of War · sub-agency 1700 · office N68171
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- N6817121P6130
- Award type code
- B
- Actions
- 7 · Sep 24, 2021 to Sep 17, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History7
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 17, 2025 | FY2025 | P00006 | G | $40,212.97 | — |
| Sep 18, 2024 | FY2024 | P00005 | G | $31,780.41 | — |
| Sep 25, 2023 | FY2023 | P00004 | G | $39,317.66 | — |
| Mar 6, 2023 | FY2023 | P00003 | M | −$944.35 | — |
| Dec 1, 2022 | FY2023 | P00002 | B | $8,939.45 | — |
| Aug 17, 2022 | FY2022 | P00001 | B | $33,590.33 | — |
| Sep 24, 2021 | FY2021 | 0 | — | $32,561.47 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.